Drug · DIN 02550423
CABTREO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 7, 2024; first marketed October 7, 2024.
- Drug Identification Number (DIN)
- 02550423
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Clindamycin, combinations D10AF51
- Class
- Human
- Record last updated
- October 1, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLINDAMYCIN PHOSPHATE | 1.2 % | W/W |
| ADAPALENE | 0.15 % | W/W |
| BENZOYL PEROXIDE | 3.1 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 14, 2024: NOC 33818New Drug Submission (NDS)